Warning: include_once(../article_type.php): failed to open stream: No such file or directory in /home/suxhorbncfos/public_html/jhnss/JHNSS.MS.ID.555598.php on line 85
Warning: include_once(): Failed opening '../article_type.php' for inclusion (include_path='.:/opt/alt/php56/usr/share/pear:/opt/alt/php56/usr/share/php') in /home/suxhorbncfos/public_html/jhnss/JHNSS.MS.ID.555598.php on line 85
Conscious Sedation in Plastic Surgery: Patient Safety and Cost Reduction Midazolam/Meperidine Conscious Sedation
Samer E Haber1, Marwan Nasr2, Fadi Sleilati3, Fady Ferran4, Nabil Hokayem5, Joseph El Khoury1* and Samer Abou Zeid3
1Resident, Department of Plastic and Reconstructive Surgery, Hotel Dieu de France Hospital, Lebanon
2Assistant Professor, Department of Plastic and Reconstructive Surgery, Hotel Dieu de France Hospital, Lebanon
3Attending in the Plastic and Reconstructive Surgery, Hotel Dieu de France Hospital, Lebanon
4Professor, Department of plastic and reconstructive surgery, Hotel Dieu de France Hospital, Lebanon
5Head of Department Plastic and Reconstructive Surgery, Hotel Dieu de France Hospital, Lebanon
Submission: March 26, 2018; Published: May 02, 2018
*Corresponding author: Joseph El Khoury, Department of Plastic and Reconstructive Surgery, Hotel Dieu de France Hospital, Alfred Naccache Blvd, Achrafieh, Beirut 1100 2160, Lebanon, Email: email@example.com
How to cite this article: Samer E H, Marwan N, Fadi S, Nabil H, Joseph E K. et al. Conscious Sedation in Plastic Surgery: Patient Safety and Cost Reduction Midazolam/Meperidine Conscious Sedation. J Head Neck Spine Surg. 2018; 2(5): 555598. DOI: 10.19080/JHNSS.2018.02.555598
Background: Conscious sedation is an anesthetic modality used in different procedures, among which are plastic surgeries. This study evaluated the efficacy and safety of the IV Midazolam - IM Meperidine conscious sedation protocol.
Methods: Adult patients undergoing elective cosmetic surgeries were enrolled. Patients were excluded if they had a history of cardiac or respiratory disease or in case of pregnancy. Patient anxiety, nausea, and pain were evaluated during and after surgery. Physician satisfaction and reported intraoperative level of sedation were also assessed. Operative time, midazolam dose, and the lowest hemoglobin saturation level in oxygen were noted. The primary outcome was postoperative recovery time while cost reduction and post operative complications were considered as secondary outcome measures.
Results: 173 patients were recruited. 61.8% under went rhinoplasty procedures and 13.8% under went blepharoplasty. Mean recovery time was 196 minutes. Age was the most significant predictor of recovery time. Older patients recovered faster (p=0.019), were less anxious preoperatively (p=0.003) and had less postoperative pain (p=0.007) and nausea (p<0.0001). Higher dose of Midazolam were associated with more intraoperative anxiety (p=0.02) and an increased postoperative nausea (p=0.047) and emesis (p=0.032). We also can note that High (7-14 glasses/week) alcohol intake was associated with slower discharge (p=0.022).
Conclusions: The IM Meperidine-IV Midazolam conscious sedation protocol in plastic surgery operations in the one-day-surgery setting seems to be safe reproductible and cost effective.
Conscious sedation or "Procedural Sedation and Analgesia (PSAA)” is the modality in which sedative agents are administered (with or without analgesics) to induce a minimally depressed level of consciousness sufficient to perform certain procedures. The strict definition requires that the patient be responsive to verbal command at all times and maintain airway patency and protective reflexes. It has been used across numerous specialties to perform invasive surgical, endoscopic, and intravascular procedures of limited durations; these include orthopedic, oral, plastic, neuroendovascular, cardiac, gastric, and radiological procedures [1-8]. The technique has been widely employed in plastic surgery thanks to the advantages it has over other anesthetic modalities, namely lower costs, faster recovery, better patient and surgeon satisfaction, and lower morbidity . The surgical use of conscious sedation requires the concomitant administration of local anesthetic agents in order to achieve appropriate analgesia in the intraoperativeas well as the postoperative setting. Conscious sedation technique aims at attaining three main objectives when employed in plastic surgery: to reduce or eliminate the pain associated with injection of local anesthetic, to reduce or eliminate patient apprehension, and to reduce or eliminate recall of the operation . This study aims to describe and evaluate the safety and efficacy of an IV Midazolam-IM Meperidine (Pethidine) conscious sedation protocol that has been in use for three decades over thousands of patients at our institution in patients under going elective cosmetic surgeries.
Institutional Review Board approval was obtained. Patients aged eighteen years or older undergoing elective surgical procedures under conscious sedation provided their written informed consent to participate in the study.
This prospective study recruited patients at the Department of Plastic Surgery in major tertiary University Hospital in Beirut from November 2013 to December 2014. Patients aged eighteen years or older undergoing elective cosmetic surgical procedures, in which the Midazolam/Meperidine conscious sedation protocol is usually used, were approached and the study objectives were explained to each patient.. Patients were excluded if they had a history of cardiac or respiratory disease or in case of pregnancy.
Premedication was administered at the day care unit around thirty minutes before surgery as an intramuscular injection of Meperidine 75mg, Haloperidol 2.5mg, and Atropine 0.25mg. Surgical procedures were conducted in a specially conceived operating room where the primary surgeon and his assistant
- a resident - operate in the presence of one circulating nurse. Anesthesiologists were located nearby, readily available for intervention upon request.
In blepharoplasty procedures, oxybuprocaine eye drops (Cebesine 0.4%) were used in the immediate preoperative period while in rhinoplasty procedures, a lidocaine-based gel was applied intranasally before in filtration by the local anesthetic solution (Lidocaine 1% with 1/200,000 epinephrine).
After positioning and proper draping, a direct intravenous Midazolam dose (1 to 3 mg) was administered seconds before the infiltration by the local anesthetic solution. Sedation level could be readily verified through mild non-verbal stimulation by gently touching the patient's eyelashes and looking for a reflex response. Infiltration was then undergone, and in rhinoplasty, the nose was packed with gauze soaked in Lidocaine-based gel. Oxygen saturation level was monitored throughout the procedure and the levels of sedation and anxiety were constantly evaluated. If the patient became or remained conscious and/or anxious, the surgeon called for additional midazolam as needed. On the other hand, if the patient's respiratory rate and/or oxygen saturation decreased, the patient was verbally instructed to breathe deeply. In case the patient was not responsive to verbal stimulation, a brief jaw-thrust maneuver was applied, or, very rarely, a Guedel cannula could be inserted for airway patency or reverse medication could be administered.
The postoperative period consisted of a minimum of three hours of rest during which the patient wasn't allowed nothing per orem. After this recovery period, when the patient could autonomously walk and eat, he/she were considered ready for discharge.
Patient anxiety was evaluated before and after premedication (auto-evaluation and evaluation by the physician). Physician satisfaction was noted on a scale from zero to ten, as well as intraoperativelevel of sedation (Modified Observer's Assessment of Alertness/Sedation Scale)  at four different timepoints during surgery: 1- at infiltration of the local anesthetic, 2- fifteen minutes after the infiltration, 3- during lateral osteotomy (only in rhinoplasty procedures), and 4- during cast placement (only in rhinoplasty) (Table 1). Intraoperative nausea or emesis was also assessed. Operative time, midazolam dose, and the lowest hemoglobin saturation level in oxygen were noted. Postoperative anxiety, nausea/emesis, and pain were evaluated using a questionnaire employed in a study by Hasen et al. . The designated primary outcome was recovery time which corresponded to the time needed to regain orthostatic autonomy after the end of the operation. Discharge time - time from the end of the operation until discharge - depended less on the autonomy of the patient than on administrative and logistic issues, which meant that it was less related to the recovery from sedation than recovery time. Cost reduction, unintended admissions, pain, anxiety, nausea, emesis, and patient recall were considered the secondary outcome measures.
Statistical analyses were done using Stata. Kolmogorov- Smirnov test was undergone to test for the normality of the distribution of independent variables. Statistical relationships were studied between dependent variables and independent variables.
A total of 173 patients were recruited of which 144 were females (83.2%). Mean age was 35.2 years (95% confidence interval [32.8; 37.6] years) (Table 2). 107 patients (61.8%) underwent rhinoplasty procedures, 24 patients (13.8%) underwent blepharoplasty procedures and 42 patients (24.3%) under went other procedures (liposuction/fat grafting, otoplasty, and other procedures). Mean operative time was 59.5 minutes (95% confidence interval (CI) 56.3-62.8 minutes). Mean recovery time was 196 minutes (95% CI 181-212). None of the patients required intraoperative anesthesiologist intervention or an unintended admission. 90% of patients recalled some events from the operation while only 10% recalled an intraoperative bad experience. 10.5% of patients reported
postoperative nausea. However, when asked to rate their nausea from 0 to 10, only 15.4% of 155 patients reported a score of more than 5. Postoperative emesis was reported in 14% of patients. One patient presented to the emergency department 4 hours after discharge for extrapyramidal symptoms (trismus). She was successfully treated with a 50mg intramuscular dose of promethazine (Phenergan®). Other results are summarized in Tables 2-4.
In univariate analyses, age was the most significant predictor of recovery time. Older patients recovered faster (p=0.019), and were discharged faster (p=0.009). They were less anxious preoperatively (before (p=0.003) and after premedication (p=0.092), had less postoperative pain (p=0.007), nausea (p<0.0001), and emesis (p=0.006), and showed deeper sedation at the end of the rhinoplasty operations during cast placement (p=0.008). There was a trend towards better satisfaction with sedation in older patients (p=0.092).
Male patients were less anxious preoperatively both before (p=0.0027) and after (p=0.069) premedication, and intraoperatively (with significant patient recall of intraoperative anxiety). In rhinoplasty procedures, they were more sedated during osteotomy (p=0.0004) and during cast placement (p=0.035). They also had less vomiting episodes postoperatively (p=0.021). An average of 90.1% minimal oxygen saturation (95% confidence interval, 87.8-92.5) was noticed in all patients.
Midazolam dose was increased when intraoperative patient anxiety was reported to be high by the surgeon (p=0.011), and it was higher in patients with less deep sedation at cast placement in rhinoplasty procedures (p=0.046). Patients who had received a higher dose of Midazolam reported more intraoperative anxiety (p=0.02) and less recall of entering the operating room (p=0.0024). Higher midazolam dose was associated with increased postoperative nausea (p=0.047) and emesis (p=0.032).
Analgesic intake in the past two weeks tended to be associated with recall of events from the operation (Chi-2 test; p=0.05). 29 of 55 patients who had taken analgesics did not recall events from the operation (53%) versus 36 of 99 patients who had taken analgesics (36%).
High (7-14 glasses/week) alcohol intake was associated with slower discharge (p=0.022). In our establishment the fixed hospital cost In a conscious sedation protocol for blepharoplasty and rhinoplasty is around 700$ where it is 1700$ in a general anesthesia setting. This means a 59% cost reduction.
Conscious sedation is an anesthetic technique where the patient's consciousness level is diminished while maintaining response to verbal command. Airway protection reflexes, muscle contraction and thermal regulatory mechanisms are still present thus preventing aspiration, deep vein thrombosis (DVT), and hypothermia .
None of our patients required intraoperative anesthesiologist intervention or an unintended admission. Marcus et al.  reported 15 unintended admissions (out of 300 patients) in their study using the fentanyl/midazolam conscious sedation protocol, 73% of which was due to nausea and vomiting. Gart et al.  suggested that although the rate of unintended readmission was low in conscious sedation patients, high doses of preoperative diazepam decreased intraoperative midazolam and fentanyl use and reduced the incidence of postoperative nausea/vomiting. This strategy was found to decrease the rate on unintended admissions due to nausea and vomiting from around 1% to 0%.
In our study, the mean recovery time was 196 minutes (95% CI 181-212). This result is similar to that observed in a study comparing bolus to continuous midazolam administration (A). The recovery time for procedures of 120-180 minutes duration was 90-240 minutes. However, in other studies, intraoperative IV fentanyl rather than meperidine yielded shorter recovery times (63 minutes) but requiring an anesthesiologist .
90% of patients recalled some events from the operation while only 10% recalled an intraoperative bad experience. 10.5% of patients in our study reported postoperative nausea and 14% reported postoperative emesis. In a study comparing conscious to deep sedation, Hasen et al.  reported a 17% rate of recall of unpleasant intraoperative events in the conscious sedation group (vs. only 3% in the deep sedation group). However, both groups had low recall of intraoperative pain, anxiety, and nausea, and the deep sedation group experienced significantly more nausea in the recovery room (p = 0.002), at the time of discharge (p = 0.009), and the evening after the operation (p = 0.013). Amnesia of intraoperative events confers conscious sedation a similar patient experience to that of general anesthesia. Absence of inhalational anesthetics and the low dose of narcotics decrease postoperative nausea and vomiting (PONV) . PONV is often referred to by patients as the most unpleasing issue in the entire operative experience. It is closely associated with propofol and with high intraoperative opioid use which favors conscious sedation over general anesthesia - where propofol and high opioid doses are employed - and propofol-based deep sedation [3,13]. PONV incidence in benzodiazepine/opioid-based conscious sedation is reportedly higher amongst women and in the 6-16 years age group (34-51%), with decreasing incidence with age (14-40%) . Our results fall into these limits with 15.4% of patients reporting a nausea score of 6 or more on a scale from 0 to 10, with female sex predisposition, and decreased PONV with advancing age.
In their study on fentanyl/midazolam conscious sedation, Marcus et al.  reported a negative correlation between recovery time and advancing (p <0.001). Similar results were obtained in our study where older patients recovered faster (p=0.019), and were discharged faster (p=0.009).
While general anesthesia remains the corner stone for most surgeries, it has a 1 to 50,000 fatality rate mainly due to thromboembolic events . It also presents a risk of malignant hyperthermia and a 30% rate of post-operative nausea and vomiting despite proper anti-emetic measures, not to mention increased costs, hospital admissions, preoperative evaluation time, post-operative recovery time, and complications from oro-tracheal intubation (sore throat, tooth injury, atelectasis) [1,10,13,14]. On the other hand, conscious sedation decreases the risk of thromboembolic events without DVT prophylaxis [9,15], decreases hospital stay, unintended admissions, and costs, and eliminates the need for a tracheal tube [1,10,15,16].
Many protocols have been described for conscious sedation in plastic surgery; benzodiazepines are the most commonly used while propofol, ketamine and barbiturates are fairly found in some regimens [17-26]. Agents with a short duration of activity/ half-life are preferred and they are used in small incremental doses while constantly monitoring patient's alertness, respiratory rate and room air oxygen saturation. Multiple agents
- propofol, ketamine, and midazolam - possess this property. However, the advantages that midazolam has include amnestic properties and reversibility, with increased patient satisfaction and safety, respectively Propofol and Ketamine lack reversibility and their use by non-anesthesiologists remains controversial . Midazolam is a short-acting benzodiazepine that provides sedation, anxiolysis, and antegrade amnesia and these effects are potentiated by opioid agents. The increased hypnotic effect of midazolam with age and in females is well documented in the literature [4,5,27] and is clearly reflected in the results of this study. It should be noted that the need for sedation is not uniform throughout the procedure. An initial loading dose is required prior to the infiltration of the local anesthetic . Once pain suppression is established, the depth of sedation needed becomes less important. The patient is hence allowed to gradually regain consciousness during the operation. Another bolus dose is usually added towards the end of rhinoplasty procedures prior to the lateral osteotomy to alleviate anxiety secondary to the sounds and vibrations generated by percussion. This explains why only 10% of our patients recalled peroperative bad experience while 67% recalled events from the operation. As for side effects, Midazolam-induced respiratory depression is primarily manifested by a decrease in respiratory rate while decreased oxygen saturation only comes next. Therefore, monitoring of the patient's oxygen saturation at room air but also of the respiratory rate must take place concurrently . Our technique proved to be safe with an average of 90.1% minimal oxygen saturation (95% confidence interval, 87.8-92.5).
More we can notice in Figure 1 that the septoplasty added to rhinoplasty increases the risk of post-operative nausea by 2.5
folds (Figure 1). We can also add that rhinoplasty in conscious sedation setting or general anesthesia if not associated with septoplasty present with similar post operative emesis and nausea. Finally a key factor to consider is a reduction of 60% of the patient hospital cost with no increase in complications and a earlier recovery than general anesthesia.
This study provides further evidence on the safety and effectiveness of the IM Meperidine - IV Midazolam conscious sedation protocol in plastic surgery operations in the one-day- surgery setting. It has been used at our institution for more than twenty years over thousands of patients with no major complications occurring. Further studies are needed to compare the fentanyl/midazolam regimen with this meperidine/ midazolam protocol with or without dexmedetomidine in terms of safety, efficacy, and cost-effectiveness.